100mill
U.S. adults are now living with diabetes or prediabetes
600,000
people are killed by tobacco-caused disease
60%
North Americans live where air pollution is at unhealthy levels
Members of The Union North America Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union North America Region consists of organisational and individual members
American Friends of The Union
Created in 2023, The American Friends fights for the eradication of tuberculosis and other lung diseases, primarily through support of The Union.
The charity was established by Union members, including a former President and Board members.
Held in February 2020, the 24th Annual Conference of The Union North America Region is a three-day scientific conference organised by Union members, which brings together hundred experts of national and international renown to discuss regional perspectives on global health issues including TB, lung health and related topics.
Professor Guy Marks, President of The Union, welcomed delegates to the first day of the conference.
Union news from the North America Region
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.